alantolactone has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Z; Gao, S; Huang, K; Huang, M; Li, X; Liu, N; Liu, S; Liu, T; Liu, X; Lu, C; Mao, J; Miao, S; Ning, W; Qi, M; Qin, S; Sheng, P; Su, C; Sun, T; Wei, L; Wei, Y; Xiao, T; Yang, C; Yang, G; Zhao, L; Zhou, H | 1 |
1 other study(ies) available for alantolactone and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Synthesis and discovery of a drug candidate for treatment of idiopathic pulmonary fibrosis through inhibition of TGF-β1 pathway.
Topics: Animals; Bleomycin; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Fibroblasts; High-Throughput Screening Assays; Idiopathic Pulmonary Fibrosis; Lactones; Mice; Molecular Structure; NIH 3T3 Cells; Sesquiterpenes; Sesquiterpenes, Eudesmane; Structure-Activity Relationship; Transforming Growth Factor beta1 | 2018 |